Insider Transactions in Q3 2023 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
1,290
-3.07%
|
$11,610
$9.41 P/Share
|
|
Sep 18
2023
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,436
-1.67%
|
$12,924
$9.41 P/Share
|
|
Sep 18
2023
|
Joshua T Brumm CEO & President |
SELL
Open market or private sale
|
Direct |
12,032
-4.9%
|
$108,288
$9.41 P/Share
|
|
Sep 18
2023
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,672
-2.49%
|
$24,048
$9.41 P/Share
|
|
Sep 18
2023
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,261
-2.04%
|
$11,349
$9.41 P/Share
|
|
Sep 12
2023
|
Wildon Farwell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,707
-1.88%
|
$17,070
$10.41 P/Share
|
|
Sep 12
2023
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,484
-1.7%
|
$14,840
$10.41 P/Share
|
|
Sep 12
2023
|
Joshua T Brumm CEO & President |
SELL
Open market or private sale
|
Direct |
7,672
-3.03%
|
$76,720
$10.41 P/Share
|
|
Sep 12
2023
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,635
-1.5%
|
$16,350
$10.41 P/Share
|
|
Sep 12
2023
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,266
-2.01%
|
$12,660
$10.41 P/Share
|
|
Sep 12
2023
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
1,397
-3.21%
|
$13,970
$10.41 P/Share
|